#1 Clinical Trials Search in Europe

Ferumoxytol

Ferumoxytol, also known by the brand name Feraheme, is an intravenous iron replacement product originally approved for treating iron deficiency anemia in patients with chronic kidney disease. However, recent clinical trials are exploring its potential in various other medical applications, particularly as a contrast agent for magnetic resonance imaging (MRI). This article summarizes key findings from several clinical trials investigating novel uses of ferumoxytol beyond its primary indication.

Table of Contents

What is Ferumoxytol?

Ferumoxytol is a medication primarily used to treat iron deficiency anemia in patients with chronic kidney disease. It’s also known by its brand name Feraheme[1]. Ferumoxytol is classified as an iron replacement product and belongs to a group of medications called ultrasmall superparamagnetic iron oxide (USPIO) particles[2].

Other names for ferumoxytol include:

  • FERUMOXYTOL NON-STOICHIOMETRIC MAGNETITE[2]
  • Feraheme[1]
These alternative names may be used interchangeably in medical literature or by healthcare providers.

Uses of Ferumoxytol

Ferumoxytol is primarily used for:

  1. Treatment of Iron Deficiency Anemia: It’s approved for treating iron deficiency anemia in patients with chronic kidney disease[1]. Anemia is a condition where you don’t have enough healthy red blood cells to carry adequate oxygen to your body’s tissues, often caused by iron deficiency.
  2. As a Contrast Agent in Medical Imaging: Ferumoxytol is being studied as an alternative contrast agent for magnetic resonance imaging (MRI) in patients who cannot receive standard gadolinium-based contrast agents[3]. This is particularly useful for patients with kidney problems who are at risk of complications from gadolinium-based agents.

How Ferumoxytol Works

Ferumoxytol works in two main ways:

  1. As an Iron Replacement: When used to treat anemia, ferumoxytol provides iron to the body. Iron is essential for the production of hemoglobin, the protein in red blood cells that carries oxygen[1].
  2. As an Imaging Agent: When used in MRI, the iron particles in ferumoxytol affect the magnetic properties of tissues, allowing for enhanced visualization of blood vessels and certain types of cells[3]. This is particularly useful for imaging inflammation and blood flow in various conditions.

Administration and Dosage

Ferumoxytol is typically administered intravenously (through a vein). The dosage and administration schedule can vary depending on the specific use:

  • For anemia treatment, a common dosage is two 510 mg injections given 3-8 days apart[1].
  • When used as an imaging agent, the dose is usually based on body weight, often around 4-5 mg of iron per kilogram of body weight[3].
Always follow your healthcare provider’s instructions regarding dosage and administration.

Ferumoxytol in Medical Imaging

Ferumoxytol is being studied extensively for its potential in various imaging applications:

  • Brain Imaging: It’s being investigated for visualizing inflammation in brain tumors and other neurological conditions[2].
  • Vascular Imaging: Ferumoxytol can help visualize blood vessels, which is useful in diagnosing conditions like peripheral artery disease[4].
  • Cardiac Imaging: Studies are exploring its use in visualizing coronary arteries, potentially offering an alternative for patients who can’t receive standard contrast agents[5].
These applications are still being researched and are not yet standard practice.

Safety and Side Effects

While ferumoxytol is generally considered safe, it can cause side effects. Common side effects may include:

  • Dizziness
  • Headache
  • Nausea
  • Constipation
In rare cases, more serious allergic reactions can occur. Your healthcare provider will monitor you closely during and after administration[6].

Ongoing Research

Ferumoxytol is the subject of ongoing research in various areas:

  • Pediatric Use: Studies are investigating its safety and efficacy in children with chronic kidney disease and iron deficiency anemia[7].
  • Neurological Conditions: Research is exploring its potential in imaging brain inflammation in conditions like HIV-associated cognitive disorders[8].
  • Cardiovascular Imaging: Studies are assessing its use in visualizing coronary arteries, particularly in patients with kidney problems[5].
These studies aim to expand our understanding of ferumoxytol’s potential uses and benefits in various medical fields.

Trial Focus Key Findings/Objectives Potential Impact
Enhanced MRI in Epilepsy Using ferumoxytol to improve visualization of hippocampal blood vessels in temporal lobe epilepsy May improve prediction of surgical outcomes in epilepsy patients
Iron Deficiency Anemia Treatment Evaluating safety and efficacy of ferumoxytol for episodic treatment of iron deficiency anemia Could provide an alternative treatment option for patients with chronic anemia
Peripheral Arterial Disease Imaging Comparing ferumoxytol-enhanced MRI to non-contrast MRA for detecting arterial stenosis May offer a safer imaging option for patients with kidney disease
Coronary Artery Disease Detection Assessing ferumoxytol-enhanced cardiac MRI for detecting coronary artery stenosis Could provide a non-invasive alternative to coronary angiography
Brain Imaging in HIV-associated Cognitive Disorders Investigating ferumoxytol as a biomarker for monocyte/macrophage infiltration in the brain May improve understanding and diagnosis of HIV-associated cognitive impairment
Pulmonary Embolism Diagnosis Exploring ferumoxytol-enhanced MRI for diagnosing pulmonary embolism in patients with kidney disease Could provide a safer diagnostic option for patients unable to receive traditional contrast agents

FAQ

  • What is ferumoxytol and what is it primarily used for? Ferumoxytol is an intravenous iron replacement product. It is primarily approved for treating iron deficiency anemia in patients with chronic kidney disease.
  • How is ferumoxytol being used in MRI studies? Ferumoxytol is being investigated as a contrast agent for MRI, particularly for visualizing blood vessels and detecting abnormalities in various parts of the body, including the brain, heart, and lungs.
  • What advantages does ferumoxytol have over traditional contrast agents? Ferumoxytol may be safer for patients with kidney problems compared to traditional iodine-based or gadolinium-based contrast agents, which can cause complications in these patients. It also allows for longer imaging times due to its longer half-life in the body.
  • Are there any potential risks associated with using ferumoxytol? While generally considered safe, ferumoxytol can cause side effects like other medications. Common side effects may include nausea, dizziness, and headache. Rarely, more serious allergic reactions can occur. Always consult with a healthcare provider about potential risks.
  • What new areas of medicine are being explored with ferumoxytol in clinical trials? Clinical trials are exploring ferumoxytol's use in various areas, including enhanced MRI for detecting coronary artery disease, pulmonary embolism, and brain abnormalities in HIV-associated cognitive disorders. It's also being studied for its effects on inflammation and oxidative stress markers in kidney disease patients.

Ongoing Clinical Trials on Ferumoxytol

  • Study comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children

    Recruiting

    1 1 1 1
    Investigated drugs:
    Lithuania Poland

  • Comparing ferumoxytol and iron sucrose for treating iron deficiency anemia in children with chronic kidney disease

    Recruiting

    1 1 1 1
    Investigated drugs:
    Hungary Lithuania Poland

Glossary

  • Ferumoxytol: An intravenous iron replacement product used to treat iron deficiency anemia, also being investigated as a contrast agent for magnetic resonance imaging.
  • Iron Deficiency Anemia: A condition where there is a lack of healthy red blood cells due to insufficient iron in the body.
  • Chronic Kidney Disease (CKD): A condition characterized by gradual loss of kidney function over time.
  • Magnetic Resonance Imaging (MRI): A medical imaging technique that uses strong magnetic fields and radio waves to produce detailed images of the body's internal structures.
  • Contrast Agent: A substance used to improve the visibility of internal body structures in medical imaging.
  • Transferrin Saturation (TSAT): A blood test that measures how much iron is bound to transferrin, a protein that carries iron in the blood.
  • Hemoglobin: A protein in red blood cells that carries oxygen throughout the body.
  • Peripheral Arterial Disease (PAD): A circulatory condition in which narrowed arteries reduce blood flow to the limbs.
  • Nephrogenic Systemic Fibrosis: A rare but serious condition that can occur in patients with kidney disease after exposure to certain types of contrast agents.
  • Pulmonary Embolism: A blockage in one of the pulmonary arteries in the lungs, often caused by blood clots that travel from other parts of the body.

References

  1. https://clinicaltrials.gov/study/NCT01114217
  2. https://clinicaltrials.gov/study/NCT03179449
  3. https://clinicaltrials.gov/study/NCT02452216
  4. https://clinicaltrials.gov/study/NCT00707876
  5. https://clinicaltrials.gov/study/NCT02954510
  6. https://clinicaltrials.gov/study/NCT01374919
  7. https://clinicaltrials.gov/study/NCT01264679
  8. https://clinicaltrials.gov/study/NCT01665846